Journal of Leukocyte Biology, Vol 65, Issue 4 458-465, Copyright © 1999 by Society for Leukocyte Biology
JOURNAL ARTICLE |
J Rappaport, J Joseph, S Croul, G Alexander, L Del Valle, S Amini and K Khalili
Center for NeuroVirology and NeuroOncology, MCP Hahnemann University, Philadelphia, Pennsylvania 19102, USA.
The broad range of histological lesions associated with HIV-1 are somewhat subtle relative to the clinical manifestations that occur as a result of HIV infection. Although it is clear that HIV has a causative role in CNS disease, dementia appears to be a consequence of the infiltration of inflammatory cells and cytokine dysregulation rather than the amount of virus in CNS. The HIV transregulatory protein Tat plays an important intracellular as well as extracellular role in the dysregulation of cytokines. The cytokines and possibly chemokines that are induced by Tat modify the action of astrocytes such that the survival of neurons is compromised. Pathogenetic alteration induced by Tat involves a series of interactions between circulating monocyte/macrophages, endothelial cells, and astrocytes. Cytokine dysregulation induced by viral infection and extracellular Tat leads to alterations in expression of adhesion molecules and promotes migration of non-infected inflammatory cells into the CNS compartment. We demonstrate here that recombinant HIV-1 Tat protein introduced by stereotaxic injection into mouse brain can induce pathologically relevant alterations including macrophage invasion as well as astrocytosis. The mechanism of destruction of the CNS by Tat appears to involve autocrine and paracrine pathways that depend not only on Tat, but cytokine and chemokine signaling pathways that are altered by viral infection. In this review, we discuss various pathogenic effects of Tat in brain cells and provide experimental evidence for an increased TNF-alpha level in CSF in mice injected intracerebrally with Tat protein.
This article has been cited by other articles:
 |
|
 |
|
  D. O. Willer, Y. Guan, M. A. Luscher, B. Li, R. Pilon, J. Fournier, M. Parenteau, M. A. Wainberg, P. Sandstrom, and K. S. MacDonald Multi-Low-Dose Mucosal Simian Immunodeficiency Virus SIVmac239 Challenge of Cynomolgus Macaques Immunized with "Hyperattenuated" SIV Constructs J. Virol., March 1, 2010; 84(5): 2304 - 2317. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. R. Campbell, J. D. Watkins, K. K. Singh, E. P. Loret, and S. A. Spector Human Immunodeficiency Virus Type 1 Subtype C Tat Fails To Induce Intracellular Calcium Flux and Induces Reduced Tumor Necrosis Factor Production from Monocytes J. Virol., June 1, 2007; 81(11): 5919 - 5928. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K Khalili and M K White Human demyelinating disease and the polyomavirus JCV Multiple Sclerosis, April 1, 2006; 12(2): 133 - 142. [Abstract] [PDF]
|
|
|
|
 |
|
 M. R. Zocchi, P. Contini, M. Alfano, and A. Poggi Pertussis Toxin (PTX) B Subunit and the Nontoxic PTX Mutant PT9K/129G Inhibit Tat-Induced TGF-{beta} Production by NK Cells and TGF-{beta}-Mediated NK Cell Apoptosis J. Immunol., May 15, 2005; 174(10): 6054 - 6061. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Wong, A. Sharma, S. Awasthi, E. F. Matlock, L. Rogers, C. Van Lint, D. J. Skiest, D. K. Burns, and R. Harrod HIV-1 Tat Interactions with p300 and PCAF Transcriptional Coactivators Inhibit Histone Acetylation and Neurotrophin Signaling through CREB J. Biol. Chem., March 11, 2005; 280(10): 9390 - 9399. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. K. Avraham, S. Jiang, T.-H. Lee, O. Prakash, and S. Avraham HIV-1 Tat-Mediated Effects on Focal Adhesion Assembly and Permeability in Brain Microvascular Endothelial Cells J. Immunol., November 15, 2004; 173(10): 6228 - 6233. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. O. Kim, Y. Liu, B. Y. Zhou, and J. J. He Induction of C Chemokine XCL1 (Lymphotactin/Single C Motif-1{alpha}/Activation-Induced, T Cell-Derived and Chemokine-Related Cytokine) Expression by HIV-1 Tat Protein J. Immunol., February 1, 2004; 172(3): 1888 - 1895. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. O. Kim, Y. Liu, Y. Ruan, Z. C. Xu, L. Schantz, and J. J. He Neuropathologies in Transgenic Mice Expressing Human Immunodeficiency Virus Type 1 Tat Protein under the Regulation of the Astrocyte-Specific Glial Fibrillary Acidic Protein Promoter and Doxycycline Am. J. Pathol., May 1, 2003; 162(5): 1693 - 1707. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Chauhan, J. Turchan, C. Pocernich, A. Bruce-Keller, S. Roth, D. A. Butterfield, E. O. Major, and A. Nath Intracellular Human Immunodeficiency Virus Tat Expression in Astrocytes Promotes Astrocyte Survival but Induces Potent Neurotoxicity at Distant Sites via Axonal Transport J. Biol. Chem., April 4, 2003; 278(15): 13512 - 13519. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Guan, J. B. Whitney, M. Detorio, and M. A. Wainberg Construction and In Vitro Properties of a Series of Attenuated Simian Immunodeficiency Viruses with All Accessory Genes Deleted J. Virol., May 1, 2001; 75(9): 4056 - 4067. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Guan, J. B. Whitney, C. Liang, and M. A. Wainberg Novel, Live Attenuated Simian Immunodeficiency Virus Constructs Containing Major Deletions in Leader RNA Sequences J. Virol., March 15, 2001; 75(6): 2776 - 2785. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Cho, J. Park, O. Yoo, and K. Kim Translocation and accumulation of exogeneous hepatitis B virus preS surface proteins in the cell nucleus J. Cell Sci., January 3, 2001; 114(6): 1115 - 1123. [Abstract] [PDF]
|
|
